Another explanation for the worsening stroke prognosis in COVID-19 patients is probably the diminished use of acute stroke therapies such as tissue fibrinogen activator (t-PA) and mechanical thrombectomy (MT). The gene discussed is PLAT; the disease is COVID-19.